Controlling schistosomiasis: Significant decrease of anaemia prevalence one year after a single dose of praziquantel in Nigerien schoolchildren

PLoS Neglected Tropical Diseases

Volumn 2, Issue 5, 2008, Pages

  Tohon, Zilahatou B ^a   Mainassara, Halima B ^a   Garba, Amadou ^b   Mahamane, Ali E ^a   Bosqué Oliva, Elisa ^c   Ibrahim, Maman Laminou ^a   Duchemin, Jean Bernard ^a   Chanteau, Suzanne ^a,d   Boisier, Pascal ^a,e  

^a Centre de Recherche Medicale et Sanitaire Niamey   (Niger)

^b Programme National de Lutte contre la Bilharziose et les Geohelminthes   (Niger)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d Institut Pasteur de Nouvelle Caledonie Noumea   (New Caledonia)

^e CENTRE PASTEUR DU CAMEROUN   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; HEMOGLOBIN; PRAZIQUANTEL; ANTHELMINTIC AGENT;

AGE; ANEMIA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEMATURIA; HEMOGLOBIN DETERMINATION; HUMAN; INTERVIEW; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; METHEMOGLOBINEMIA; NIGERIA; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PREDICTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SCHOOL CHILD; SINGLE DRUG DOSE; URINALYSIS; WORLD HEALTH ORGANIZATION; CHILD; CLINICAL TRIAL; PATHOLOGY; TREATMENT OUTCOME;

ANEMIA; ANTHELMINTICS; CHILD; FEMALE; HUMANS; MALE; NIGERIA; PRAZIQUANTEL; SCHISTOSOMIASIS; TREATMENT OUTCOME;

EID: 48949118056     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000241     Document Type: Article

References (50)

1. Ernould JC, Garba A, Labbo R, Kaman AK, Sidiki A, et al. (2004) [Heterogeneity of Schistosoma haematobium transmission in irrigated fields], Bull Soc Pathol Exot 97: 19-23.
2. Mouchet F, Labo R, Develoux M, Sellin B (1987) [Survey of schistosomiasis in the Gaya district (Republic of Niger)]. Ann Soc Belg Med Trop 67: 23-29.
3. Moucbet F, Vera C, Bremond P, Devidas A, Sellin B (1990) [Urinary schistosomiasis in the Saharan mountain plateau of Air (Republic of Niger)]. Bull Soc Pathol Exot 83: 249-256.
4. Jordan P, Webbe G (1993) Epidemiology. In: Jordan P, Webbe G, Sturrock RF, eds. Human schistosomiasis. Wallingford, UK: CAB International. pp 87-158.
5. Degremont A, Burki A, Burnier E, Schweizer W, Meudt R, et al. (1985) Value of ultrasonography in investigating morbidity due to Sschistasoma haematobium infection. Ianoet 1: 662-665.
6. Doehring E, Ehrich JH, Reider F, Dittrich M, Schmidt-Ehry G, et al. (1985) Morbidity in urinary schistosomiasis: relation between sonographical lesions and pathological urine findings. Trop Med Parasitol 36: 145-149.
7. Heurtier Y, Lamothe F, Develoux M, Docquier J, Mouchet F, et al. (1986) Urinary tract lesions due to Schistosoma haematobium infection assessed by ultrasonography in a community based study in Niger. Am J Trop Med Hyg 35: 1163-1172.
8. Hatz CF (2001) The use of ultrasound in schistosomiasis. Adv Parasitol 48: 225-284.
9. Friedman JF, Kanzaria HK, McGarvey ST (2005) Human schistosomiasis and anaemia: the relationship and potential mechanisms. Trends Pamsitol 21: 386-392.
10. Bretagne S, Roussin S, Sellin E, Rey JL, Fly Sainte Marie F, et al. (1985) [Urinary bilharziasis and sideropenic anaemia. Study of their relation in 2 villages in Niger]. Bull Soc Pathol Exot Filiales 78: 648-656.
11. Prual A, Daouda H, Develoux M, Sellin B, Galan P, et al. (1992) Consequences of Schistosoma haematobium infection on the iron status of schoolchildren in Niger. Am J Trop Med Hyg 47: 291-297.
12. Beasley NM, Tomkins AM, Hall A, Kihamia CM, Lorri W, et al. (1999) The impact of population level deworming on the haemoglobin levels of schoolchildren in Tanga, Tanzania. Trop Med Int Health 4: 744-750.
13. Ehrhardt S, Burchard GD, Mantel C, Cramer JP, Kaiser S, et al. (2006) Malaiia, anaemia, and malnutrition in african children-defining intervention priorities. J Infect Dis 194: 108-114.
14. Stephenson LS, Kinoti SN, Latham MC, Kurz KM, Kyobe J (1989) Single dose metrifonate or praziquantel treatment in Kenyan children. I. Effects on Schistosoma haematobium, hookworm, hemoglobin levels, splenomegaly, and hepatomegaly. Am J Trop Med Hyg 41: 406-444.
15. Befidi-Mengue RN, Ratard RC, Beltran G, D'Alessandro A, Rice J, et al. (1993) Impact of Schistosoma haematobium infection and of praziquantel treatment on anaemia of primary school children in Bertoua, Cameroon. J Trop Med Hyg 96: 225-230.
16. Garba A, Campagne G, Tassie JM, Barkire A, Vera C, et al. (2004) [Long-term impact of a mass treatment by praziquantel an morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger]. Bull Soc Pathol Exot 97: 7-11.
17. Katz N, Chaves A, Pellegrino J (1972) A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14: 397-400.
18. World Health Organization (1999) Monitoring helminth control programmes. Guidelines for monitoring the impact of control programmes aimed at reducing morbidity caused by soil-transmitted helminths and schistosomes, with particular reference to school-age children. Document WHO/CDS/CPC/SIP/99.3. Geneva: World Health Organization.
19. Korenromp EL, Armstrong-Schellenberg JR, Williams BG, Nahlen BL, Snow RW (2004) Impact of malaria control on childhood anaemia in Africa-a quantitative review. Trop Med Int Health 9: 1050-1065.
20. World Health Organization (2000) Ultrasound in Schistosomiasis. A Practical Guide to the Standardized Use of Ultrasonography for the Assessment of Schistosomiasis-related Morbidity. Document TDR/STR/SCH/ 00.1. Geneva: World Health Organization.
21. World Healdi Organization (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Report of a WHO expert committee. Geneva: World Health Organization.
22. Beasley M, Brooker S, Ndinaromtan M, Madjiouroum EM, Baboguel M, et al. (2002) First nationwide survey of the health of schoolchildren in Chad. Trop Med Int Health 7: 625-630.
23. Saathoff E, Olsen A, Magnussen P, Kvalsvig JD, Becker W, et al. (2004) Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa. BMC Infect Dis 4: 40.
24. Lengeler C, Utzinger J, Tanner M (2002) Questionnaires for rapid screening of schistosomiasis in sub-Saharan Africa. Bull World Health Organ 80: 235-242.
25. Montresor A, Engels D, Chitsulo L, Bundy DA, Brooker S, et al. (2001) Development and validation of a 'tablet pole' for the administration of praziquantel in sub-Saharan Africa. Trans R Soc Trop Med Hyg 95: 542-544.
26. Montresor A, Engels D, Ramsan M, Foum A, Savioli L (2002) Field test of the 'dose pole' for praziquantel in Zanzibar. Trans R Soc Trop Med Hyg 96: 323-324.
27. King CH, Muchiri E, Ouma JH, Koech D (1991) Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya. Am J Trop Med Hyg 45: 498-508.
28. Mott KE, Dixon H, Osei-Tutu E, England EC, Davis A (1985) Effect of praziquantel on haematuria and proteinuria in urinary schistosomiasis. Am J Trop Med Hyg 34: 1119-1126.
29. Campagne G, Garba A, Barkire H, Vera C, Sidiki A, et al. (2001) [Continued ultrasonic follow-up of children infected with Schistosoma haematobium after treatment with praziquantel]. Trop Med Int Health 6: 24-30.
30. Fallon PG, Sturrock RF, Niang AC, Doenhoff MJ (1995) Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 53: 61-62.
31. Doenhoff MJ, Pica-Mattoccia L (2006) Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev Anti Infect Ther 4: 199-210.
32. Develoux M, Mouchet F, Labo R (1986) [Intestinal parasitic diseases of school children in the Republic of Niger]. Bull Soc pathol Exot Filiales 79: 571-575.
33. De Clercq D, Sacko M, Behnke JM, Traore M, Vercruysse J (1995) Schistosoma and geohelminth infections in Mali, west Africa. Ann Soc Belg Med Trop 75: 191-199.
34. Serieye J, Boisier P, Ravaoalimalala VE, Ramarokoto CE, Leutscher P, et al. (1996) Schistosoma haematobium infection in western Madagascar: morbidity determined by ultrasonography. Trans R Soc Trop Med Hyg 90: 398-401.
35. Laurent C, Lamothe F, Develoux M, Sellin B, Moocher F (1990) Ultrasonographic assessment of urinary tract lesions due to Schistosoma haematobium in Niger after four consecutive years of treatment with praziquantel. Trop Med Parasitol 41: 139-142.
36. Richter J (2000) Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies. Acta Trop 77: 111-131.
37. Brouwer KC, Ndhlovu PD, Wagatsuma Y, Munatsi A, Shiff CJ (2003) Epidemiological assessment of Schistosoma haematobium-induced kidney and bladder pathology in rural Zimbabwe. Acta Trop 85: 339-347.
38. King CH, Lombardi G, Lombardi C, Greenblatt R, Hodder S, et al. (1990) Chemotherapy-based control of Schistosomiasis haematobia. II. Metrifonate vs. praziquantel in control of infection-associated morbidity. Am J Trop Med Hyg 42: 587-595.
39. Wagatsuma Y, Aryeetery ME, Sack DA, Morrow RH, Hatz C, et al. (1999) Resolution and resurgence of schistosoma haematobium-induced pathology after community-based chemotherapy in ghana, as detected by ultrasound. J Infect Dis 179: 1515-1522.
40. Devidas A, Lamothe F, Develoux M, Mouchet F, Sellin B (1989) Utrasonographic assessment of the regression of bladder and renal lesions due to Schistosoma haematobium after treatment with praziquantel. Ann Soc Belg Med Trop 69: 57-65.
41. World Health Organization (2001) Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. Document WHO/NHD/ 01.3. Geneva: World Health Organization.
42. Hall A, Bobrow E, Brooker S, Jukes M, Nokes K, et al. (2001) Anaemia in schoolchildren in eight countries in Africa and Asia. Public Health Nutr 4: 749-756.
43. Bhargava A, Jukes M, Lambo J, Kihamia CM, Lorri W, et al. (2003) Anthelmintic treatment improves the haemoglobin. and serum ferritin concentrations of Tanzanian schoolchildren. Food Nutr Bull 24: 332-342.
44. Stephenson IS, Latham MC, Kurz KM, Kinoti SN, Oduori ML, et al. (1985) Relationships of Schistosoma haematobium, bookworm and malarial infections and metrifonate treatment to growth of Kenyan school children. Am J Trop Med Hyg 34: 1109-1118.
45. Lyke KE, Dicko A, Dabo A, Sangare L, Kone A, et al. (2005) Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. Am J Trop Med Hyg 73: 1124-1130.
46. Lwambo NJ, Brooker S, Siza JE, Bundy DA, Guyatt H (2000) Age patterns in stunting and anaemia in African schoolchildren: a cross-sectional study in Tanzania. Eur J Clin Nutr 54: 36-40.
47. Koukounari A, Gabrielli AF, Toure S, Bosque-Oliva E, Zhang Y, et al. (2007) Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso. J Infect Dis 196: 659-669.
48. Bates I, McKew S, Sarkinfada F (2007) Anaemia: a useful indicator of neglected disease burden and control. PLoS Med 4: e231. doi:10.1371/ journal.pmed.0040231.
49. Molyneux DH, Hotez PJ, Fenwick A (2005) "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2: e336. doi:10.1371/journal.pmed.0020336.
50. Institut National de la Statistique (INS), Macro International Inc (2007) Enquête Démographique et de Santé et à Indicateurs Multiples du Niger 2006. Calverton, Maryland, USA: INS & Macro International Inc.